Detalhe da pesquisa
1.
Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer.
Anticancer Drugs
; 31(6): 632-636, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011363
2.
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer.
Invest New Drugs
; 37(3): 524-530, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30687871
3.
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer.
Oncotarget
; 9(32): 22332-22339, 2018 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29854281
4.
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials.
Crit Rev Oncol Hematol
; 113: 18-21, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427507
5.
Bevacizumab and weekly docetaxel in patients with metastatic castrate-resistant prostate cancer previously exposed to docetaxel.
Prostate Cancer
; 2011: 258689, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096653